Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Environmental factors acting during development to influence MS risk: insights from animal studies.
An adverse lipid profile is associated with disability and progression in disability, in people with MS.
Age and disability drive cognitive impairment in multiple sclerosis across disease subtypes.
Seizure characteristics in multiple sclerosis patients.
Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
Gut dysfunction in patients with multiple sclerosis and the role of spinal cord involvement in the disease.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Identifying Modulators of CXC Receptors 3 and 4 with Tailored Selectivity using Multi-Target Docking.
Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.
Enrichment for Northern European-derived multiple sclerosis risk alleles in Sardinia.
Individualized rituximab treatment for relapsing neuromyelitis optica: a pediatric case report.
Habitual Functional Electrical Stimulation Therapy Improves Gait Kinematics and Walking Performance, but Not Patient-Reported Functional Outcomes, of People with Multiple Sclerosis who Present with Foot-Drop.
Burden of risk variants correlates with phenotype of multiple sclerosis.
Embelin Suppresses Dendritic Cell Functions and Limits Autoimmune Encephalomyelitis Through the TGF-β/β-catenin and STAT3 Signaling Pathways.
Rotating-polarization CARS microscopy: combining chemical and molecular orientation sensitivity.
Effect of in-painting on cortical thickness measurements in multiple sclerosis: A large cohort study.
Allopregnanolone and neuroinflammation: a focus on multiple sclerosis.
Peripheral blood mononuclear cell membrane fluidity and disease outcome in patients with multiple sclerosis.
Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
Ethical considerations when counseling patients about stem cell tourism.
Acute Disseminated Encephalomyelitis.
What is the true clinicopathologic spectrum of neuromyelitis optica?
Magnetization transfer from inhomogeneously broadened lines (ihMT): Improved imaging strategy for spinal cord applications.
Dual diagnosis: rheumatoid arthritis and multiple sclerosis.
Investigating the Antigen Specificity of Multiple Sclerosis Central Nervous System-Derived Immunoglobulins.
Pages
« first
‹ previous
…
353
354
355
356
357
358
359
360
361
…
next ›
last »